Literature DB >> 32816997

New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.

Rebecca Unsworth1, Susan Wallace2, Nick S Oliver1, Shunmay Yeung3,4, Archana Kshirsagar2, Harshini Naidu5, Ruth Min Wai Kwong6, Priya Kumar6, Karen M Logan7.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32816997     DOI： 10.2337/dc20-1551

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  96 in total

1.  SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas.

Authors:  Janis A Müller; Rüdiger Groß; Carina Conzelmann; Jana Krüger; Uta Merle; Johannes Steinhart; Tatjana Weil; Lennart Koepke; Caterina Prelli Bozzo; Clarissa Read; Giorgio Fois; Tim Eiseler; Julia Gehrmann; Joanne van Vuuren; Isabel M Wessbecher; Manfred Frick; Ivan G Costa; Markus Breunig; Beate Grüner; Lynn Peters; Michael Schuster; Stefan Liebau; Thomas Seufferlein; Steffen Stenger; Albrecht Stenzinger; Patrick E MacDonald; Frank Kirchhoff; Konstantin M J Sparrer; Paul Walther; Heiko Lickert; Thomas F E Barth; Martin Wagner; Jan Münch; Sandra Heller; Alexander Kleger
Journal:  Nat Metab       Date:  2021-02-03

2.  SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.

Authors:  Chien-Ting Wu; Peter V Lidsky; Yinghong Xiao; Ivan T Lee; Ran Cheng; Tsuguhisa Nakayama; Sizun Jiang; Janos Demeter; Romina J Bevacqua; Charles A Chang; Robert L Whitener; Anna K Stalder; Bokai Zhu; Han Chen; Yury Goltsev; Alexandar Tzankov; Jayakar V Nayak; Garry P Nolan; Matthias S Matter; Raul Andino; Peter K Jackson
Journal:  Cell Metab       Date:  2021-05-18       Impact factor: 27.287

3.  The COVID-19 pandemic and associated worsening of diabetic ketoacidosis presentation in youth.

Authors:  Sonia Gera; Rachel L Longendyke; Nori M Minich; Sindhoosha Malay; Jamie R Wood
Journal:  Diabet Med       Date:  2021-06-13       Impact factor: 4.213

Review 4.  Visceral Adipose Tissue: A New Target Organ in Virus-Induced Type 1 Diabetes.

Authors:  Danny Zipris
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

5.  Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes.

Authors:  Xiaofan Jia; Patricia Gesualdo; Cristy Geno Rasmussen; Aimon A Alkanani; Ling He; Fran Dong; Marian J Rewers; Aaron W Michels; Liping Yu
Journal:  Diabetes Technol Ther       Date:  2021-02-25       Impact factor: 7.337

6.  Increase in newly diagnosed type 1 diabetes in youth during the COVID-19 pandemic in the United States: A multi-center analysis.

Authors:  Risa M Wolf; Nudrat Noor; Roberto Izquierdo; Destiny Jett; Amanda Rewers; Shideh Majidi; Nicole Sheanon; Emily Breidbart; Carla Demeterco-Berggren; Joyce M Lee; Manmohan K Kamboj; Osagie Ebekozien
Journal:  Pediatr Diabetes       Date:  2022-03-16       Impact factor: 3.409

7.  COVID-19 and diabetes mellitus. Importance of glycemic control.

Authors:  Núria Alonso; Sol Batule
Journal:  Clin Investig Arterioscler       Date:  2021 May-Jun

Review 8.  Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.

Authors:  Aikaterini Kountouri; Emmanouil Korakas; Ignatios Ikonomidis; Athanasios Raptis; Nikolaos Tentolouris; George Dimitriadis; Vaia Lambadiari
Journal:  Antioxidants (Basel)       Date:  2021-05-09

9.  Diabetes and Covid-19: Clinical implications and novel management strategies.

Authors:  R D'Arcy; C H Courtney
Journal:  Ulster Med J       Date:  2021-07-08

10.  Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data.

Authors:  Nisha Venkatesh; Natalie Astbury; Merlin C Thomas; Carlos J Rosado; Evan Pappas; Balasubramanian Krishnamurthy; Richard J MacIsaac; Thomas W H Kay; Helen E Thomas; David N O'Neal
Journal:  Diabet Med       Date:  2021-06-10       Impact factor: 4.213
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.